DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Long GV et al.
Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib.
J Clin Oncol 2016; Jan 25. pii: JCO629345. [Epub ahead of print]
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.